Back to News
Market Impact: 0.2
AngioDynamics Reiterates FY27 Outlook; Appoints Eric Honroth President And CEO
Source: Nasdaq
Corporate EarningsCorporate Guidance & OutlookHealthcare & Biotech
AngioDynamics reported first-quarter financial results and reiterated its full-year 2027 adjusted loss and net sales guidance, citing first-quarter performance and its current outlook. The provided article text contains no specific results, guidance figures, or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Rising fuel costs slashed Delta’s profit outlook despite strong demand
- ‘I drive a Tesla’: After Elon Musk said he’d lose his job, Delta CEO Ed Bastian says there’s ‘no tit for tat’ as airline unveils earnings miss
- OpenAI's revenue scare, Delta earnings, what investors think of a Starbucks-Chipotle deal and more in Morning Squawk
- Delta Air Lines cuts 2026 forecast on fuel surge, but CEO says demand is still strong
- What's behind the recovery rally in tech stocks — plus, Elon Musk's very good week
- Delta Cuts Profit Outlook as Surging Fuel Costs Tighten Grip